Apalutamide for the treatment of non‐metastatic prostate cancer
Sign Up to like & getrecommendations! Published in 2019 at "Prescriber"
DOI: 10.1002/psb.1795
Abstract: Apalutamide (Erleada) is a selective androgenreceptor inhibitor licensed for the treatment of nonmetastatic castrationresistant prostate cancer in men who are at high risk of developing metastatic disease. This article discusses its properties, efficacy and side‐effects. read more here.
Keywords: apalutamide treatment; treatment; treatment non; prostate cancer ... See more keywords
Psoriatic Skin Lesions after Apalutamide Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Acta Dermato-Venereologica"
DOI: 10.2340/actadv.v102.858
Abstract: Abstract is missing (Short communication) read more here.
Keywords: lesions apalutamide; apalutamide treatment; skin lesions; psoriatic skin ... See more keywords